健之佳上半年净利润同比增长15.11%

Core Insights - The company reported a revenue of 4.457 billion yuan and a net profit of 72.3782 million yuan for the first half of 2025, marking a year-on-year growth of 15.11% [1] Group 1: Business Transformation - The company is shifting its strategy from "meeting customer needs" to "stimulating customer demand" amidst a decline in customer traffic and average transaction value in the pharmaceutical retail industry [1] - The company is reducing its reliance on medical insurance and is deepening its transformation towards health products, specialized services, and omnichannel marketing [1] Group 2: Cost Control and Efficiency - The company has achieved a reduction in operating expenses, with a year-on-year decrease of 0.83% in total expenses for the first half of the year [1] - Continuous control over store rental, promotional, distribution, and management expenses has contributed to reversing the trend of increasing store costs [1]